Haisco Pharmaceutical Hits Day High with 9.98% Surge in Stock Price

Haisco Pharmaceutical Group Co., Ltd. has experienced a significant surge in its stock performance, gaining 9.98% on July 1, 2026. The stock reached an intraday high of CNY 72.97, reflecting strong momentum in the market. Over the past week, Haisco has shown impressive growth of 25.77%, and its one-month performance stands at 45.54%. In the context of the broader market, Haisco's performance has notably outpaced the China Shanghai Composite, which recorded a modest gain of 0.44% for the day. Year-to-date, Haisco has achieved a remarkable 42.17% increase, further solidifying its position as a strong performer in the pharmaceuticals and biotechnology sector. The company's financial metrics indicate robust growth, with a net profit increase of 1089.85% reported in March 2026. Haisco's operating cash flow reached a record high of CNY 1,126.55 million, and its return on capital employed (ROCE) stands at 17.13%. With a market capitalization of CNY 24,889 million, Haisco continues to demonstrate resilience and consistent returns over the past three years, outperforming the China Shanghai Composite in each of the last three annual periods.